Andrea Baragetti Redefines the Dialogue Between Heart and Kidney at EAS Milan
Andrea Baragetti, Associate Professor of Pharmacology at University of Milan, posted on LinkedIn:
”On the frontline of cardiovascular innovation
In Milan, at the European Atherosclerosis Society Advanced Course on Non-Classical Risk Factors, I had the privilege to stand among brilliant scientists and clinicians united by a single mission – to challenge what’s known and redefine the limits of cardiovascular and metabolic medicine.
Gratitude to the organizers and the European Atherosclerosis Society (EAS) for the opportunity to contribute with a talk on upfront therapeutic perspectives on cardio-renal syndrome – a field where the heart and kidney engage in a silent but relentless dialogue, and where every new insight can shift the balance between failure and recovery.
Science is a weapon, innovation is a creed.”
Keep up with Hemostasis Today.
-
May 18, 2026, 14:47Ting Yuan: Understanding the Complexity Behind Repeated IVF Failure
-
May 18, 2026, 14:33Global Resolution on Advancing Comprehensive Care and Health Equity for People with Bleeding Disorders Worldwide at the 79th WHA – WFH
-
May 18, 2026, 14:25Salih Ehsan: Key Diagnostic Clues in Thalassemia Minor
-
May 18, 2026, 14:02Matteo Foschi: A Global Gathering for Stroke Innovation and Research at ESOC 2026
-
May 18, 2026, 14:01Who is the NBA? – Haemophilia Foundation Australia
-
May 18, 2026, 14:00Julie Makani: Partnership between Tanzania and the USA – Health Sciences
-
May 18, 2026, 13:58Alejandro González Veliz: Cardiology Enters the Era of Inflammation
-
May 18, 2026, 13:50Arshad-Ali Auhammad: Celebrating Youth Leadership in the Global Bleeding Disorders Community
-
May 18, 2026, 13:36Zain Khalpey: In Cardiovascular Medicine Flow Is Everything